NCT05559008 2022-11-09A Umbrella Study in R/R PTCL Guided by Molecular SubtypesRuijin HospitalPhase 1/2 Unknown116 enrolled
NCT04052659 2021-03-09Sintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCLPeking UniversityPhase 2 Unknown30 enrolled